QUVIVIQ (daridorexant) – Europe s first dual orexin receptor antagonist – is now available for patients with chronic insomnia disorder in Italy and Germany streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
QUVIVIQ™ is indicated for the treatment of adult patients with insomnia characterized by symptoms present for at least three months and considerable impact.
Ad hoc announcement pursuant to Art. 53 LR Idorsia announces financial results for the first nine months of 2022 - QUVIVIQ becoming a global brand Allschwil, Switzerland - October 25, 2022Idorsia
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - July 26, 2022 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first half of 2022. Commercial highlights QUVIVIQ
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - April 26, 2022 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first quarter of 2022. Business highlights PIVLAZ